>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Jumat, 16 April 2010

JP Morgan - Buy Indo banks ahead of 1Q10 results

>> Despite the suggested adoption of IFRS starting in 1Q10, Indo banks are still reluctant to write-back general provisions to boost their book value per share or net income. They have all chosen the prudent approach. Some banks are not even ready with their accounting systems.

>> But......Indo banks should see better-than-ever correlation between loan growth and net profit growth, sequentially. Because of the IFRS, they will likely make less bad debt provisioning on new loans.

>> JPMorgan is forecasting BBCA to post a loan growth of 2% qoq and 18% yoy. BDMN to post 1.4%/flat. BMRI to post 1.6%/13%. BBRI to post 1.2%/27%.

>> For state banks, CEO changes will happen in May, potentially affecting BMRI, BBRI, and BBNI. The state banks CEO may be incentivized to show as good as possible performance ahead of the change.

>> BBRI may post strongest yoy and qoq loan growth, so 1Q10 may still act as a positive driver for the stock (JPMorgan research rates U/W). For this bank, 1Q10 results will be a balancing act between higher provision need for new NPL creation, against lower provision need for new loan creation. I think the balance will tilt towards the latter for 1Q10 (Sales call: Trading Buy).

>> BMRI will also post strong yoy loan growth, while provision will (almost) certainly decline from the high base last year. Our contrarian view on the bank is that (1) there will be no rights issue in 2010, (2) less than 50% chance of rights issue in 2011, and (3) more than 50% chance that Agus Marto will stay as CEO.

>> Sales call - buy state banks BBRI, BMRI, and BBNI.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News